Effect of Oxygen During Percutaneous Coronary Intervention for Pain Relief

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 300 participants.

Also called NCT01413841

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 300 participants (enrolled count) (from the registry)
Sponsor
  • Region Skane Registry lists this organization as the lead sponsor
Registry
  • NCT NCT01413841
Other papers using this trial's data
  • The analgesic effect of oxygen during percutaneous coronary intervention (the OXYPAIN Trial) Acute cardiac care, 2013-09 DOI, PubMed 23957447

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Sweden (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01413841. Randomized; triple masking; primary purpose treatment. Start 2011-07 (registry gives no type); primary completion 2012-06 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effect of Oxygen During Percutaneous Coronary Intervention for Pain Relief
Acronym
OXYPAIN
Condition
Angina
Intervention (Drug)
Nasal oxygen
Intervention (Drug)
Regular nasal air
Lead sponsor
Region Skane (class: other)

Record details

Record id
cardio:ct-nct01413841
Content hash
a7305f3a4355f6aff11a076f199d456f402bbbbdbe5bebad8e47caad5bc317e3